 |
| The use of benoxaprofen, formerly marketed as Oraflex tablets, was associated with fatal cholestatic jaundice among other serious adverse reactions. The holder of the approved application voluntarily withdrew Oraflex tablets from the market on August 5, 1982. |
| Brands | Coxigon
Inflamid
Opren
Oraflex
Uniprofen
|
| Categories | Lipoxygenase Inhibitors
Dermatologic Agents
|
| Synonyms | (1)-2-(4-Chlorophenyl)benzoxazole-5-propionic acid
2-(2-(4-Chlorophenyl)-1,3-benzoxazol-5-yl)propanoic acid
2-(4-Chlorophenyl)-alpha-methyl-5-benzoxazoleacetic acid
2-[2-(4-Chlorophenyl)-1,3-benzoxazol-5-yl]propanoic acid
Benoxaprofene [inn-french]
Benoxaprofeno [inn-spanish]
Benoxaprofenum [inn-latin]
DL-benoxaprofen
|
Terms of Use
|
|
